A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression
Cellular Oncology · 2025
DOI: 10.1007/s13402-025-01111-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Fanbin Zeng und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China. Hauptthemen laut MEDLINE: Carbolines, Colorectal Neoplasms, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-mdm2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China.
- Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen, Guangdong, 518107, China.
- Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
- College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, 518060, China.
- Pathology Department, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, No. 3002 Shungang West Road, Shenzhen, 518035, China.
- National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, 200437, China.
Zitieren
APA
Zeng, F., Chen, C., Fu, Z., Huang, H., Cui, W., Zhou, Y., Kong, Y., Liu, X., Xu, Z., Wang, S., Xiao, T., & Xia, H. (2025). A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression. Cellular Oncology. https://doi.org/10.1007/s13402-025-01111-3
Vancouver
Zeng F, Chen C, Fu Z, Huang H, Cui W, Zhou Y, et al. A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression. Cellular Oncology. 2025. doi:10.1007/s13402-025-01111-3
BibTeX
@article{Zeng2025,
author = {Zeng, Fanbin and Chen, Cheng and Fu, Zhanwei and Huang, Haihui and Cui, Wenqiang and Zhou, Yuanyuan and Kong, Yanjie and Liu, Xia and Xu, Zhiru and Wang, Shouguo and Xiao, Tian and Xia, Houjun},
title = {A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-025-01111-3}
}
EUVIMED